Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2025 12:30 ET | Source: Smith & Nephew UK Ltd

Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural...
September 30, 2025 11:27 ET | Source: Research and Markets

North America Orthobiologics Market Outlook Report 2018-2033 - Focus on Cartilage Repair, Bone Grafts and Substitutes, and Bone Growth Stimulators

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "North America Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators and Others" has been...
September 30, 2025 11:24 ET | Source: Research and Markets

United States Orthobiologics Market Outlook Report 2023-2033

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "United States Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators and Others" report has...
June 29, 2025 07:00 ET | Source: Smith & Nephew UK Ltd

Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The...
May 07, 2025 08:00 ET | Source: Smith & Nephew UK Ltd

Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

The CARTIHEAL Implant will be featured at the Arthroscopy Association of North America Annual Meeting (AANA 2025) this week Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company,...
March 10, 2025 11:00 ET | Source: Smith & Nephew UK Ltd

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of...
December 11, 2024 11:39 ET | Source: Research and Markets

Bone Marrow Aspirate Concentrates Industry Report, Featuring Profiles of 45+ Key Players Including Arthrex, Cesca Therapeutics, Globus Medical, Ranfac, Terumo and Zimmer Biomet Holdings

Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Bone Marrow Aspirate Concentrates - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Bone...
December 04, 2024 11:00 ET | Source: Research and Markets

North America Orthobiologics Market Outlook 2018-2033 Featuring Sanofi, Medtronic, and Stryker

Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "North America Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others" report has been added to ResearchAndMarkets.com's...
November 25, 2024 07:29 ET | Source: Research and Markets

China Orthobiologics Market Outlook to 2033, Focusing on Orthobiologics and Cartilage Repair

Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "China Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others" report has been added to ResearchAndMarkets.com's...
March 04, 2024 05:00 ET | Source: CYTOMED THERAPEUTICS LIMITED

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...